HDAC9 and colorectal cancer: HDAC inhibitor decreases HDAC1K412 lactylation to sensitize colorectal cancer to ferroptosis and the combination of HDAC inhibitor and ferroptosis inducers can be a promising therapeutic strategy for colorectal cancer.